Innate Pharma SA 20-F for FY2020
Innate Pharma SA (IPHA)
20-F
2021-04-27
For: 2020-12-31
View Original
Added on
April 06, 2026
About this 20-F
Innate Pharma SA filed this 20-F on April 27, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 70.45M EUR
- down 17.9% from 85.81M EUR a year earlier
- Net loss
- 63.98M EUR
- compared with a net loss of 20.76M EUR a year earlier
- Diluted EPS
- -0.81 EUR
- compared with -0.31 EUR a year earlier